Skip to content
Screener

Azenta AZTA Sample Management Solutions and Multiomics — Total Assets

Other segment segments

Multiomics
$324.98M-27.0%

Similar metrics at other companies

AerSale Corporation logo
ASLEAsset Management Solutions — Total Assets
$445.87M+4.9%
Equitable Holdings logo
EQHAsset Management — Total Assets
$10.34B-3.4%
KKR & Co. logo
KKRAsset Management — Total Assets
$28.02B-0.3%
Apollo Global Management logo
APOAsset Management — Total Assets
$21.76B+44.5%
Asset Entities logo
ASSTAsset Management — Total Assets
$1.3M
Rithm Capital logo
RITMAsset management — Total Assets
$4.5B+84.6%

Other financials

Income statement

See full
Revenue$161.2M+12.0%
Gross profit$72.4M+9.0%
Operating income-$4.2M-126%
Net income$2.5M+105%
EPS (diluted)$0.05+105%

Balance sheet

See full
Cash & equivalents$70.8M
Total debt$54.0M
Total equity$1.5B-9.7%
Total assets$1.9B

Cash flow

See full
Operating cash flow$1.4M-94.4%
CapEx$6.6M-38.7%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.48B+15.1%
Enterprise value$1.46B
P/S2.4×+0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-20%+1.5pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-7.7%
Debt / equity
Current ratio2.5×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Azenta’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054295
Assets:June 30, 2026September 30, 2025
Sample Management Solutions$822,668$854,402
Multiomics324,984445,212
Total assets$1,147,652$1,299,614

Item 1. Financial Statements

FAQ

What is Azenta's sample management solutions and multiomics — total assets?
Azenta (AZTA) reported sample management solutions and multiomics — total assets of $1.15B in Q2 2026.
What does sample management solutions and multiomics — total assets mean?
This metric represents the total carrying value of assets specifically allocated to the Sample Management Solutions and Multiomics business segment. It encompasses the infrastructure, inventory, and specialized equipment required to support cold-chain sample management and genomic services for life sciences clients. Monitoring these assets provides insight into the capital intensity and operational scale of the company's core service offerings within the drug development and clinical research markets.

Ask your AI about Azenta's sample management solutions and multiomics — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude